Close Menu

NEW YORK – Boston-based NanoView Biosciences said today that it has signed an exclusive agreement with Alfatest, headquartered in Rome, to distribute its ExoView platform in Italy.

The research-use-only ExoView platform is an antibody labeling and imaging-based extracellular vesicle detection system that provides size analysis, vesicle count, phenotyping, and biomarker colocalization. According to the company, it requires minimal sample input, no sample prep or purification, and can be used directly with complex biological samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.